Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report

The intrauterine device (IUD) is the most popular method of reversible contraception in women of reproductive age nowadays, and its use is being reported by nearly 160 million women. It is considered safe and effective, but intrauterine devices are associated with rare complications such as uterine...

Descripción completa

Detalles Bibliográficos
Autor principal: Roman, Jose D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744392/
https://www.ncbi.nlm.nih.gov/pubmed/36523665
http://dx.doi.org/10.7759/cureus.31398
_version_ 1784848916358889472
author Roman, Jose D
author_facet Roman, Jose D
author_sort Roman, Jose D
collection PubMed
description The intrauterine device (IUD) is the most popular method of reversible contraception in women of reproductive age nowadays, and its use is being reported by nearly 160 million women. It is considered safe and effective, but intrauterine devices are associated with rare complications such as uterine perforation. We report a case of uterine perforation by a levonorgestrel-releasing intrauterine device (LNG-IUD), Mirena (Bayer, Auckland, New Zealand) levonorgestrel 52 mg, to create awareness of the diagnosis and the laparoscopic management of these rare cases.
format Online
Article
Text
id pubmed-9744392
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97443922022-12-14 Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report Roman, Jose D Cureus Family/General Practice The intrauterine device (IUD) is the most popular method of reversible contraception in women of reproductive age nowadays, and its use is being reported by nearly 160 million women. It is considered safe and effective, but intrauterine devices are associated with rare complications such as uterine perforation. We report a case of uterine perforation by a levonorgestrel-releasing intrauterine device (LNG-IUD), Mirena (Bayer, Auckland, New Zealand) levonorgestrel 52 mg, to create awareness of the diagnosis and the laparoscopic management of these rare cases. Cureus 2022-11-12 /pmc/articles/PMC9744392/ /pubmed/36523665 http://dx.doi.org/10.7759/cureus.31398 Text en Copyright © 2022, Roman et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Roman, Jose D
Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
title Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
title_full Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
title_fullStr Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
title_full_unstemmed Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
title_short Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
title_sort uterine perforation by levonorgestrel-releasing intrauterine device: a case report
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744392/
https://www.ncbi.nlm.nih.gov/pubmed/36523665
http://dx.doi.org/10.7759/cureus.31398
work_keys_str_mv AT romanjosed uterineperforationbylevonorgestrelreleasingintrauterinedeviceacasereport

Ejemplares similares